Skip to content

Investigating the effectiveness of Lycopene on the Hemodynamic status of Coronary artery bypass graft surgery candidates

Investigating the effectiveness of Lycopene on the Hemodynamic status of Coronary artery bypass graft surgery candidates in Shahid Chamran Hospital, Isfahan in 2024

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
IRCT
Registry ID
IRCT20231006059634N2
Enrollment
80
Registered
2024-11-29
Start date
2024-03-20
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics of coronary bypass patients. Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris

Interventions

Intervention 1: Intervention group: Coronary bypass patients will be treated with Lycopene by Vitabiotics with a dose of 30 mg 12 hours before the operation. Intervention 2: Control group: Coronary by

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Coronary artery bypass graft surgery candidate Age between 40 and 70 years Having knowledge and consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Patients under ANH Addiction to psychotropics

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: Before induction of anesthesia, during the operation and then every 4 hours after the operation up to 48 hours during hospitalization in the ICU. Method of measurement: Based on launch with Arterline.;Diastolic blood pressure. Timepoint: Before induction of anesthesia, during the operation and then every 4 hours after the operation up to 48 hours during hospitalization in the ICU. Method of measurement: Based on launch with Arterline.;Mean arterial pressure. Timepoint: Before induction of anesthesia, during the operation and then every 4 hours after the operation up to 48 hours during hospitalization in the ICU. Method of measurement: Based on launch with Arterline.

Secondary

MeasureTime frame
Inotrope consumption. Timepoint: During the operation and then up to 48 hours during hospitalization in the ICU. Method of measurement: Based on the amount of inotrope injected.;Arrhythmia. Timepoint: During the operation and then up to 48 hours during hospitalization in the ICU. Method of measurement: View of ECG.;CRP level. Timepoint: During the operation and then up to 48 hours during hospitalization in the ICU. Method of measurement: Based on a blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Naseri Nasab

Esfahan University of Medical Sciences

hosseinna1994@gmail.com+98 31 5261 0180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026